The new report by Expert Market Research titled, ‘Middle East and Africa In-Vitro Diagnostics Market Share, Report and Forecast 2023-2028’, gives an in-depth analysis of the Middle East and Africa in-vitro diagnostics market, assessing the market based on its segments like products and services, technologies, applications, end-uses, and major countries.
The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Middle East and Africa In-Vitro Diagnostics Market Size, Trends, Industry Report, Key Player, Major Segments, and Forecast
Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/middle-east-and-africa-in-vitro-diagnostics-market/requestsample
The key highlights of the report include:
Market Overview (2018-2028)
• Forecast CAGR (2023-2028): 3.2%
The introduction of new technologies and growing penetration of private independent laboratories have led to significant progress in the clinical laboratory segment in the UAE and Saudi Arabia. Thus, there has been a distinct shift towards independent labs from hospital-based laboratories with technological advancements. Such developments will likely augment the Middle East and Africa in-vitro diagnostics market.
Also, there has been considerable demand for rapid, economical, easy-to-use POCT devices for infectious disease diagnostics in the UAE, thereby propelling the Middle East and Africa in-vitro diagnostics market. The adoption of managed clinical services in the region’s hospitals, the need for next-generation sequencing testing for genetic testing, and smart labs-as-a-service for automation of laboratory services are other prominent sectors with great growth potential.
Middle East and Africa In-Vitro Diagnostics Industry Definition and Major Segments
Early warning indications and specific risk factors can be found using in-vitro diagnostics, offering up new opportunities for prevention and early intervention. With the use of some in-vitro diagnostics, people with chronic illnesses can self-monitor and manage their own symptoms outside of the constraints of the lab, hospital, or doctor’s office.
By product and service, the market is segmented into:
• Reagents and Kits
• Software and Services
By technology, the Middle East and Africa in-vitro diagnostics market is classified into:
• Clinical Chemistry
• Molecular Diagnostics
• Blood Glucose Self-Monitoring
• Coagulation and Haemostasis
By application, the market is divided into:
• Infectious Diseases
• Autoimmune Diseases
By end use, the Middle East and Africa in-vitro diagnostics market is classified into:
On the basis of country, the market is classified into:
• Saudi Arabia
• United Arab Emirates
• South Africa
Middle East and Africa In-Vitro Diagnostics Market Trends
The rise in the use of personalised medicines in the treatment of various chronic diseases, such as cancer, is adding to the growth of the Middle East and Africa in-vitro diagnostics market. The rising awareness related to the use of in-vitro diagnostics is another major factor contributing to the growth in-vitro diagnostics market in the region.
Users can now simply do tests to check their blood glucose levels, identify a urinary tract infection, track their ovulation, and confirm pregnancy. These tests help people maintain their health and provide fast answers to support further medical action. These benefits are anticipated to propel the in-vitro diagnostics market in Middle East and Africa.
Key Market Players
The major players in the market are:
- Becton, Dickinson and Company
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- Surmodics IVD, Inc.
- Illumina, Inc.
The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skillful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Company Name: Claight Corporation
Contact Person: Shira Ellis, Corporate Sales Specialist – U.S.A.
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Leave a Reply